1Tavassoli FA,Devilee P.WHO classification of tumors.Pathology & genetics,tumors of the breast and female genital organs.Lyon:IARC Press,2003.
2Cocquyt V,Van Belle S.Lobular carcinoma in situ and invasive lobular cancer of the breast.Curr Opin Obstet Gynecol,2005,17:55-60.
3Bratthauer GL,Moinfar F,Stamatakos MD,et al.Combined Ecadherin and high molecular weight cytokeratin immunoprofile differentiated lobular,ductal,and hybrid mammary intraepithelial neoplasias.Hum Pathol,2002,33:620-627.
4Tavassoli FA.Tumor of the Breast.Proceedings of 118th Semi-Annual Seminar,June 4-6,2005.California:California Tumor Tissue Registry.
5Cutuli B,deLafontan B,Quetin P,Mery E.Breast-c onserving surgery radiotherapy:a possible treatment for lobular carcinoma in situ.Eur J Cancer,2005,41:380-385.
6Jones C,Merrett S,Thomas VA,et al.Comparative genomic hybridisation of bilateral hyperplasia of usual type of the breast.J Pathol,2003,199:152-156.
7Lininger RA,Fujii H,Man YG,et al.Comparison of loss of heterozygosity in primary and recurrent ductal carcinoma in situ of the breast.Mod Pathol,1998,11:1151-1159.
8Moinfar F,Man Y-G,Bratthauer GL,et al.A genetic abnormality in ductal intraepithelial neoplasia of the flat type of the breast.Cancer,2000,88:2072-2081.
9Eusebi V,Feudale F,Foschini MP,et al.Long-term follow-up of in situ carcinoma of the breast.Semin Deagno Pathol,1994,11:223-235.
10Tavassoli FA,Purcell CL,Bratthauer GL,et al.Androgen receptor positivity along with loss of bcl-2,ER,and PR expression in benign and malignant apocrine lesions of the breast.Implications for therapy.Breast J,1996,2:1-10.
